Latest Prostate-specific antigen Stories
17% Increase in Test Volume, 11% Increase in Total Revenue and 29% Increase in International Product Revenue Compared to Prior Year REDWOOD CITY, Calif., Aug.
Study Achieved Primary Endpoint of Predicting Recurrence after Surgery and Reconfirmed Original Adverse Pathology Endpoint from Published UCSF Validation Study REDWOOD CITY, Calif.,
Active Surveillance Provides Low-Risk Patients Less Harmful Treatment Option NORTHFIELD, Ill., Aug.
Demands Manufacturers Prove Claims of Safety and Benefits For Prostate Cancer Treatments CORAL SPRINGS, Fla., Aug.
OXFORD, England, July 29, 2014 /PRNewswire/ -- Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer.
LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Humility of Mary Health Partners will provide free PSA blood draws to check 100 men for prostate cancer during the Fuel the Fight car and motorcycle show June 1 at Boardman High School.
-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International
Panel discusses long-term effect on quality of life ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- A series of studies evaluating the outcomes, benefits, concerns and quality of life
- The parings of haberdine; also, any kind of fragments.